ArticleImmunotherapy2020

Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens.

José-María Díez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.